Resources Contact Us Home
Systems, methods and computer programs for determining dependencies between logical components in a data processing system or network

Image Number 9 for United States Patent #8132180.

Described are methods, apparatus and computer programs for determining run-time dependencies between logical components of a data processing environment. Components of the data processing environment are monitored by monitoring agents accessing run-time activity data via APIs of the managed system. A dependency generator identifies correlations between the run-time activity of the monitored components. For synchronous monitored systems, the dependency generator calculates an activity period for monitored components and determines which component's activity periods contain the activity periods of other components. Containment is used as an indicator of a likely dependency relationship, and a weighting is computed for each dependency relationship based on the consistency of containment.

  Recently Added Patents
Apparatus and method for controlling a tunable matching network in a wireless network
Display screen with graphical user interface
Chair structure
Message transfer apparatus, output method, and computer program product
Method for computing an energy efficient route
Flip-chip mounting resin composition and bump forming resin composition
Configuration method and system of complex network and configuration and management module of server resources
  Randomly Featured Patents
Low spill farm coupling
Colorless ophthalmic glasses
Printing with self-cleaning, abrasion-resistant, laser-imageable lithographic printing constructions
Intra-oral ice pack
Air distribution system and manifold for cooling electronic components
Compositions encoding lepidopteran-toxic polypeptides and methods of use
Cecropin polypetides with activity against Gram-positive and Gram-negative bacteria
System and method for distributing and accessing files in a distributed storage system
Managing the business of a medical scheme
Administration of pirenzepine, methyl scopolamine and other muscarinic receptor antagonists for treatment of lipid metabolism disorders